Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04059224
Title TraMel-WT: A Trial of Trametinib in Patients With Advanced Pretreated BRAFV600 Wild-type Melanoma (TraMel-WT)
Acronym TraMel-WT
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Universitair Ziekenhuis Brussel
Indications
Therapies
Age Groups: adult | senior
Covered Countries BEL

Additional content available in CKB BOOST